Associated Papers
Autosomal dominant myopathy caused by a novel ISCU variant.
Rusecka JM et al.
Frontiers in Genetics, 2025
Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution.
Richter-Pechańska P et al.
Leukemia, 2022
35585141 (PubMed )
Supplement: 41375_2022_1587_MOESM1_ESM.xlsx › Suppl.Tab.1
Outlining the Complex Pathway of Mammalian Fe-S Cluster Biogenesis.
Maio N et al.
Trends in Biochemical Sciences, 2020
PTBP1 acts as a dominant repressor of the aberrant tissue-specific splicing of ISCU in hereditary myopathy with lactic acidosis.
Rawcliffe DFR et al.
Molecular Genetics & Genomic Medicine, 2018
A novel de novo dominant mutation in ISCU associated with mitochondrial myopathy.
Legati A et al.
Journal of Medical Genetics, 2017
Select a paper to view details